Header cover image

Nigerian (NSE) Pharma Industry Analysis

UpdatedMay 22, 2024
DataAggregated Company Financials
Companies4
  • 7D-1.3%
  • 3M-1.3%
  • 1Y59.1%
  • YTD-6.9%

Over the last 7 days, the Pharma industry has dropped 1.3%, driven by declines from every company within the industry. In the past year, the industry has gained 59%.

Industry Valuation and Performance

Has the Nigerian Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 23 May 2024₦93.8b₦84.6b₦1.9b9.7x50.1x1.1x
Sat, 20 Apr 2024₦93.4b₦75.0b₦1.8b9.8x51.2x1.2x
Mon, 18 Mar 2024₦91.7b₦75.0b₦1.7b10.1x54.4x1.2x
Wed, 14 Feb 2024₦100.6b₦75.0b₦1.7b11.4x59.7x1.3x
Fri, 12 Jan 2024₦122.5b₦85.6b₦4.7b11.6x25.9x1.4x
Sun, 10 Dec 2023₦126.7b₦85.6b₦4.7b11.5x26.8x1.5x
Tue, 07 Nov 2023₦67.5b₦85.6b₦4.7b11.2x14.3x0.8x
Thu, 05 Oct 2023₦64.7b₦82.7b₦5.7b7.8x11.3x0.8x
Sat, 02 Sep 2023₦70.3b₦82.7b₦5.7b8.8x12.2x0.9x
Mon, 31 Jul 2023₦59.6b₦82.8b₦6.2b7.8x9.6x0.7x
Wed, 28 Jun 2023₦55.6b₦81.7b₦6.1b6.5x9.1x0.7x
Fri, 26 May 2023₦44.0b₦81.7b₦6.1b5x7.2x0.5x
Sun, 23 Apr 2023₦41.5b₦83.3b₦6.1b4.9x6.8x0.5x
Tue, 21 Mar 2023₦45.0b₦83.3b₦6.3b5.5x7.1x0.5x
Thu, 16 Feb 2023₦41.6b₦83.3b₦6.3b5.3x6.6x0.5x
Sat, 14 Jan 2023₦40.8b₦83.8b₦7.3b4.8x5.6x0.5x
Mon, 12 Dec 2022₦38.1b₦83.8b₦7.3b4.3x5.2x0.5x
Wed, 09 Nov 2022₦36.1b₦81.6b₦7.7b4x4.7x0.4x
Fri, 07 Oct 2022₦37.6b₦81.7b₦7.2b7x5.2x0.5x
Sun, 04 Sep 2022₦40.0b₦81.7b₦7.2b7.2x5.5x0.5x
Tue, 02 Aug 2022₦39.2b₦78.2b₦6.3b6.7x6.2x0.5x
Thu, 30 Jun 2022₦41.9b₦76.4b₦6.4b7x6.5x0.5x
Sat, 28 May 2022₦42.8b₦76.3b₦5.8b7.6x7.4x0.6x
Mon, 25 Apr 2022₦35.5b₦67.9b₦4.9b9.2x7.2x0.5x
Wed, 23 Mar 2022₦35.0b₦67.9b₦4.7b10.5x7.4x0.5x
Fri, 18 Feb 2022₦36.3b₦67.9b₦4.7b10.9x7.7x0.5x
Sun, 16 Jan 2022₦34.5b₦61.7b₦4.9b7x7x0.6x
Tue, 14 Dec 2021₦30.9b₦61.5b₦4.7b6.9x6.6x0.5x
Thu, 11 Nov 2021₦33.1b₦61.5b₦4.7b7.5x7x0.5x
Sat, 09 Oct 2021₦32.1b₦55.8b₦3.6b8.2x8.9x0.6x
Mon, 06 Sep 2021₦32.8b₦62.2b₦2.8b8x11.8x0.5x
Wed, 04 Aug 2021₦32.3b₦62.2b₦2.8b8.1x11.6x0.5x
Price to Earnings Ratio

9.8x


Total Market Cap: ₦29.3bTotal Earnings: ₦3.0bTotal Revenue: ₦61.7bTotal Market Cap vs Earnings and Revenue0%0%0%
Nigerian Pharma Industry Price to Earnings3Y Average 13.8x202220232024
Current Industry PE
  • Investors are optimistic on the Nigerian Pharmaceuticals industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 50.1x which is higher than its 3-year average PE of 13.8x.
  • The 3-year average PS ratio of 0.69x is lower than the industry's current PS ratio of 1.1x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have declined 14% per year over the last three years.
  • Meanwhile revenues for these companies have grown 11% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the Nigerian Healthcare industry?

NG Market-1.15%
Healthcare-1.27%
Pharma-1.31%
Pharma-1.31%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
No data available
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

MAYBAKER

₦6.70

May & Baker Nigeria

7D

-4.3%

1Y

67.5%

NEIMETH

₦1.70

Neimeth International Pharmaceuticals

7D

-8.1%

1Y

22.3%